1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM...

30
1 Epidermal Growth Factor Receptor Epidermal Growth Factor Receptor (EGFR) (EGFR) the transmembrane + juxtamembrane the transmembrane + juxtamembrane domains domains L1 CR1 L2 CR2 JM Kinase CT 644 151 312 481 621 687 955 1186 Extracellular portion Intracellular portion L1 CR1 L2 CR2 JM Kinase CT 644 151 312 481 621 687 955 1186 Extracellular portion Intracellular portion The transmembrane + juxtamembrane part (615-686 a.a. + N- The transmembrane + juxtamembrane part (615-686 a.a. + N- terminal 7His-tag) contains the transmembrane and the terminal 7His-tag) contains the transmembrane and the regulatory juxtamembrane (JM) domain regulatory juxtamembrane (JM) domain

Transcript of 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM...

Page 1: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

11

Epidermal Growth Factor Receptor (EGFR)Epidermal Growth Factor Receptor (EGFR)the transmembrane + juxtamembrane domainsthe transmembrane + juxtamembrane domainsEpidermal Growth Factor Receptor (EGFR)Epidermal Growth Factor Receptor (EGFR)

the transmembrane + juxtamembrane domainsthe transmembrane + juxtamembrane domains

L1 CR1 L2 CR2 JM Kinase CT

644

151 312 481 621 687 955 1186

Extracellular portion Intracellular portion

L1 CR1 L2 CR2 JM Kinase CT

644

151 312 481 621 687 955 1186

Extracellular portion Intracellular portion

The transmembrane + juxtamembrane part (615-686 a.a. + N-terminal 7His-tag) The transmembrane + juxtamembrane part (615-686 a.a. + N-terminal 7His-tag) contains the transmembrane and the regulatory juxtamembrane (JM) domaincontains the transmembrane and the regulatory juxtamembrane (JM) domain

Page 2: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

22

Important information about the tj-EGFRImportant information about the tj-EGFRImportant information about the tj-EGFRImportant information about the tj-EGFR

73 amino acid residues (without tag)73 amino acid residues (without tag) carries N-terminal 7His-tagcarries N-terminal 7His-tag molecular weight is about 9,112 Damolecular weight is about 9,112 Da pI is around 11.5pI is around 11.5 contains no Cys residuescontains no Cys residues contains no aromatic residues (Trp, Tyr or Phe)contains no aromatic residues (Trp, Tyr or Phe)

NMR structure of the juxtamembrane domain is availableNMR structure of the juxtamembrane domain is availableChoowongkomonChoowongkomon et alet al. (2005), J. Biol. Chem.. (2005), J. Biol. Chem.

Page 3: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

33

Short overview of the work doneShort overview of the work doneShort overview of the work doneShort overview of the work done

1.1. tj-hEGFR in DMtj-hEGFR in DM

Me-affinityMe-affinity reverse phasereverse phase cation exchangecation exchange

2.2. tj-hEGFR in OGtj-hEGFR in OG

Me-affinityMe-affinity reverse phasereverse phase cation exchangecation exchange size exclusionsize exclusion

3.3. tj-hEGFR in N-tj-hEGFR in N-lauryl sarcosinelauryl sarcosine

Me-affinityMe-affinity cation exchangecation exchange size exclusionsize exclusion

4.4. tj-hEGFR in ureatj-hEGFR in urea

Me-affinityMe-affinity size exclusionsize exclusion

Page 4: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

44

Expression and solubilization of tj-EGFR in pET Expression and solubilization of tj-EGFR in pET 27b+ in 27b+ in E.coliE.coli BL21(DE3) Codon Plus RP BL21(DE3) Codon Plus RP

Expression and solubilization of tj-EGFR in pET Expression and solubilization of tj-EGFR in pET 27b+ in 27b+ in E.coliE.coli BL21(DE3) Codon Plus RP BL21(DE3) Codon Plus RP

m 1 2 3 4 5 6m 1 2 3 4 5 6

m – marker (BenchMark)m – marker (BenchMark)1 – cells, clone #1 before induction1 – cells, clone #1 before induction2 – cells, clone #1 after induction2 – cells, clone #1 after induction3 – cell lysate, supernatant3 – cell lysate, supernatant4 – cell lysate, pellet4 – cell lysate, pellet

5 – solubilization in 2% DM, supernatant5 – solubilization in 2% DM, supernatant6 – solubilization in 2% DM, pellet6 – solubilization in 2% DM, pellet

1515

1010

2020

Page 5: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

55

buffer A = 50 mM NaP pH 8.0, 0.05% (w/v) DMbuffer A = 50 mM NaP pH 8.0, 0.05% (w/v) DMbuffer B = buffer A + 1 M NaClbuffer B = buffer A + 1 M NaCl

Pilot purification of tj-EGFR in DM on Pilot purification of tj-EGFR in DM on HiTrap SP FF 1 mlHiTrap SP FF 1 ml

Pilot purification of tj-EGFR in DM on Pilot purification of tj-EGFR in DM on HiTrap SP FF 1 mlHiTrap SP FF 1 ml

m b 1 2 3 4 5 6 7 8m b 1 2 3 4 5 6 7 8 9 11 12 13 14 15 16 17 18 m9 11 12 13 14 15 16 17 18 m

m – marker (BenchMark)m – marker (BenchMark)b – sample before applicationb – sample before application

1515

1010

2020

1515

1010

2020

Page 6: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

66

buffer A = 300 mM NaCl, 50 mM NaP pH 8.0,buffer A = 300 mM NaCl, 50 mM NaP pH 8.0,0.05% (w/v) DM0.05% (w/v) DMbuffer B = buffer A + 500 mM imidazolebuffer B = buffer A + 500 mM imidazole

also tried to use 250 mM histidine for elution:also tried to use 250 mM histidine for elution:CuCu2+2+ ions elute at low histidine concentrations ions elute at low histidine concentrations

Pilot purification of tj-EGFR in DM on Pilot purification of tj-EGFR in DM on HiTrap Chelating 1 mlHiTrap Chelating 1 ml

Pilot purification of tj-EGFR in DM on Pilot purification of tj-EGFR in DM on HiTrap Chelating 1 mlHiTrap Chelating 1 ml

m b 2 9 10 11 13 15 17 19m b 2 9 10 11 13 15 17 19

m – marker (BenchMark)m – marker (BenchMark)b – sample before applicationb – sample before application

1515

1010

2020

Page 7: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

77

Scaling of purification of tj-EGFR in DM on Scaling of purification of tj-EGFR in DM on HiTrap Chelating 1 mlHiTrap Chelating 1 ml

Scaling of purification of tj-EGFR in DM on Scaling of purification of tj-EGFR in DM on HiTrap Chelating 1 mlHiTrap Chelating 1 ml

m b 1 2 3 4 5 6 7 8m b 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 17 19 9 10 11 12 13 14 15 17 19 mm

m – marker (BenchMark)m – marker (BenchMark)b – sample before applicationb – sample before applicationm 14 16 17 18 20 22m 14 16 17 18 20 22

1515

1010

2020

1515

1010

2020

2020

1515

2525

Page 8: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

88

buffer A = 0.1% (w/v) TFAbuffer A = 0.1% (w/v) TFAbuffer B = 0.08% (w/v) TFA, 80% (v/v) acetonitrilebuffer B = 0.08% (w/v) TFA, 80% (v/v) acetonitrile

Pilot purification of tj-EGFR in DM on Pilot purification of tj-EGFR in DM on RESOURCE RPC 3 mlRESOURCE RPC 3 ml

Pilot purification of tj-EGFR in DM on Pilot purification of tj-EGFR in DM on RESOURCE RPC 3 mlRESOURCE RPC 3 ml

m 2 4 7 8 12 13 14 17 18m 2 4 7 8 12 13 14 17 18

m – marker (Precision Plus)m – marker (Precision Plus)

2020

1515

2525

Page 9: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

99

buffer A = 300 mM NaCl, 50 mM NaP pH 8.0,buffer A = 300 mM NaCl, 50 mM NaP pH 8.0,0.88% (w/v) OG0.88% (w/v) OGbuffer B = buffer A + 500 mM imidazolebuffer B = buffer A + 500 mM imidazole

Pilot purification of tj-EGFR in OG on Pilot purification of tj-EGFR in OG on HiTrap Chelating 1 mlHiTrap Chelating 1 ml

Pilot purification of tj-EGFR in OG on Pilot purification of tj-EGFR in OG on HiTrap Chelating 1 mlHiTrap Chelating 1 ml

m b 2 8 9 10 12 14 16 18m b 2 8 9 10 12 14 16 18

m – marker (BenchMark)m – marker (BenchMark)b – sample before applicationb – sample before application

1515

1010

2020

Page 10: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

1010

Scaling of purification of tj-EGFR in OG Scaling of purification of tj-EGFR in OG Hitrap Chelating SepharoseHitrap Chelating Sepharose

Scaling of purification of tj-EGFR in OG Scaling of purification of tj-EGFR in OG Hitrap Chelating SepharoseHitrap Chelating Sepharose

m S FT W1 W2 Em S FT W1 W2 E

m – marker (Precision Plus)m – marker (Precision Plus)S – sample before application S – sample before application (solubilized protein)(solubilized protein)FT – flow-throughFT – flow-throughW1 – wash 1W1 – wash 1W2 – wash 2W2 – wash 2E – elution E – elution

2020

1515

2525

Page 11: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

1111

Reconstitution of tj-EGFR in DMPC liposomesReconstitution of tj-EGFR in DMPC liposomesReconstitution of tj-EGFR in DMPC liposomesReconstitution of tj-EGFR in DMPC liposomes

SDS-gelSDS-gel His-blotHis-blot

m OG rec rec_s/_pm OG rec rec_s/_p m OG rec rec_s/_pm OG rec rec_s/_p

m – marker (BenchMark)m – marker (BenchMark)OG – sample before OG – sample before reconstitution (in 0.88% OG)reconstitution (in 0.88% OG)rec – reconstituted proteinrec – reconstituted proteinrec_s – rec, supernatantrec_s – rec, supernatantrec_p – rec, pelletrec_p – rec, pellet

1515

1010

2020

1515

1010

2020

Page 12: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

1212

CD spectrum of tj-EGFR and CD spectrum of tj-EGFR and secondary structure predictionsecondary structure predictionCD spectrum of tj-EGFR and CD spectrum of tj-EGFR and secondary structure predictionsecondary structure prediction

buffer = 50 mM NaP pH 6.0, 10% Dbuffer = 50 mM NaP pH 6.0, 10% D22O, 0.88% (w/v) OGO, 0.88% (w/v) OG

Page 13: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

1313

buffer A = 50 mM NaP pH 8.0, buffer A = 50 mM NaP pH 8.0, 0.88% (w/v) OG0.88% (w/v) OGbuffer B = buffer A + 1 M NaClbuffer B = buffer A + 1 M NaCl

Pilot purification of tj-EGFR in OG on Pilot purification of tj-EGFR in OG on HiTrap SP FF 1 mlHiTrap SP FF 1 ml

Pilot purification of tj-EGFR in OG on Pilot purification of tj-EGFR in OG on HiTrap SP FF 1 mlHiTrap SP FF 1 ml

m b 2 4 5 6 9 10 11 12m b 2 4 5 6 9 10 11 12 13 14 15 16 17 18 19 20 21 m13 14 15 16 17 18 19 20 21 m

m – marker (BenchMark)m – marker (BenchMark)b – sample before applicationb – sample before application

1515

1010

2020

1515

1010

2020

Page 14: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

1414

buffer A = 50 mM NaP pH 11.7, buffer A = 50 mM NaP pH 11.7, 0.88% (w/v) OG0.88% (w/v) OGbuffer B = buffer A + 1 M NaClbuffer B = buffer A + 1 M NaCl

Pilot purification of tj-EGFR in OG on Pilot purification of tj-EGFR in OG on HiTrap SP FF 1 mlHiTrap SP FF 1 ml

Pilot purification of tj-EGFR in OG on Pilot purification of tj-EGFR in OG on HiTrap SP FF 1 mlHiTrap SP FF 1 ml

b m 2 3 8 11 12 13 15 16b m 2 3 8 11 12 13 15 16

m – marker (BenchMark)m – marker (BenchMark)b – sample before applicationb – sample before application

1515

1010

2020

Page 15: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

1515

buffer A = 50 mM Gly-NaOH pH 8.6, buffer A = 50 mM Gly-NaOH pH 8.6, 0.88% (w/v) OG0.88% (w/v) OGbuffer B = 50 mM Gly-NaOH pH 10.6, buffer B = 50 mM Gly-NaOH pH 10.6, 0.88% (w/v) OG0.88% (w/v) OG

Pilot purification of tj-EGFR in OG on Pilot purification of tj-EGFR in OG on HiTrap SP FF 1 mlHiTrap SP FF 1 ml

Pilot purification of tj-EGFR in OG on Pilot purification of tj-EGFR in OG on HiTrap SP FF 1 mlHiTrap SP FF 1 ml

2 4 6 8 m 19 20 21 22 23 24 25 26 27 282 4 6 8 m 19 20 21 22 23 24 25 26 27 28 m 29 30 31 32 33 34 35 36 37 38 39 40 41 42m 29 30 31 32 33 34 35 36 37 38 39 40 41 42

m – marker (BenchMark)m – marker (BenchMark)

Page 16: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

1616

buffer A = 50 mM NaP pH 8.0, buffer A = 50 mM NaP pH 8.0, 0.88% (w/v) OG0.88% (w/v) OGbuffer B = 50 mM NaP pH 11.5, buffer B = 50 mM NaP pH 11.5, 0.88% (w/v) OG0.88% (w/v) OG

Pilot purification of tj-EGFR in OG on Pilot purification of tj-EGFR in OG on HiTrap SP FF 1 mlHiTrap SP FF 1 ml

Pilot purification of tj-EGFR in OG on Pilot purification of tj-EGFR in OG on HiTrap SP FF 1 mlHiTrap SP FF 1 ml

b m 2 4 8 14 16 18 20 22b m 2 4 8 14 16 18 20 22 24 26 28 30 32 34 36 38 40 m24 26 28 30 32 34 36 38 40 m

m – marker (BenchMark)m – marker (BenchMark)b – sample before applicationb – sample before application

1515

1010

2020

1515

1010

2020

Page 17: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

1717

buffer A = 50 mM NaP pH 8.0, buffer A = 50 mM NaP pH 8.0, 0.88% (w/v) OG0.88% (w/v) OGbuffer B = buffer A + 1 M NaClbuffer B = buffer A + 1 M NaCl

Pilot purification of tj-EGFR in OG onPilot purification of tj-EGFR in OG onMini S 4.6/50 PEMini S 4.6/50 PE

Pilot purification of tj-EGFR in OG onPilot purification of tj-EGFR in OG onMini S 4.6/50 PEMini S 4.6/50 PE

m 3 8 25 30 31 32 33 34 35m 3 8 25 30 31 32 33 34 35 37 39 41 43 45 47 49 51 52 m37 39 41 43 45 47 49 51 52 m

m – marker (BenchMark)m – marker (BenchMark)

1515

1010

2020 1515

1010

2020

Page 18: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

1818

buffer A = 0.1% (w/v) TFAbuffer A = 0.1% (w/v) TFAbuffer B = 0.08% (w/v) TFA, 80% (v/v) acetonitrilebuffer B = 0.08% (w/v) TFA, 80% (v/v) acetonitrile

Pilot purification of tj-EGFR in OG on Pilot purification of tj-EGFR in OG on RESOURCE RPC 3 mlRESOURCE RPC 3 ml

Pilot purification of tj-EGFR in OG on Pilot purification of tj-EGFR in OG on RESOURCE RPC 3 mlRESOURCE RPC 3 ml

m 7 12 24 33 35 38 39 40 42m 7 12 24 33 35 38 39 40 42

m – marker (BenchMark)m – marker (BenchMark)

also tried to use TEA instead of TFA:also tried to use TEA instead of TFA:much worse separationmuch worse separation

1515

1010

2020

Page 19: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

1919

buffer A = 20 mM NaP pH 7.0buffer A = 20 mM NaP pH 7.0buffer B = 70% (v/v) acetonitrilebuffer B = 70% (v/v) acetonitrile

Pilot purification of tj-EGFR in OG on Pilot purification of tj-EGFR in OG on RESOURCE RPC 3 mlRESOURCE RPC 3 ml

Pilot purification of tj-EGFR in OG on Pilot purification of tj-EGFR in OG on RESOURCE RPC 3 mlRESOURCE RPC 3 ml

m 10 11 13 15 16 and 22-35m 10 11 13 15 16 and 22-35

m – marker (BenchMark)m – marker (BenchMark)

Page 20: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

2020

buffer A = 0.08% (w/v) TFA, 70% (v/v) acetonitrilebuffer A = 0.08% (w/v) TFA, 70% (v/v) acetonitrile

Pilot purification of tj-EGFR in OG on Pilot purification of tj-EGFR in OG on Peptide Superdex 10/300 GLPeptide Superdex 10/300 GL

Pilot purification of tj-EGFR in OG on Pilot purification of tj-EGFR in OG on Peptide Superdex 10/300 GLPeptide Superdex 10/300 GL

m 11 12 13 14 15 16 17 22 23m 11 12 13 14 15 16 17 22 23

m – marker (BenchMark)m – marker (BenchMark)

15151010

2020

Page 21: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

2121

buffer A = 150 mM NaCl,buffer A = 150 mM NaCl,50 mM NaP pH 8.0,50 mM NaP pH 8.0,0.88% (w/v) OG0.88% (w/v) OG

Pilot purification of tj-EGFR in OG on Pilot purification of tj-EGFR in OG on Superdex 200 10/300 GLSuperdex 200 10/300 GL

Pilot purification of tj-EGFR in OG on Pilot purification of tj-EGFR in OG on Superdex 200 10/300 GLSuperdex 200 10/300 GL

m 5 8 9 10 11 12 13 14 15m 5 8 9 10 11 12 13 14 15

m – marker (BenchMark)m – marker (BenchMark)

18 19 20 21 22 23 24 25 26 m18 19 20 21 22 23 24 25 26 m

1515

1010

20201515

1010

2020

Page 22: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

2222

Pilot purification of tj-EGFR in sarcosine Pilot purification of tj-EGFR in sarcosine Hitrap Chelating SepharoseHitrap Chelating Sepharose

Pilot purification of tj-EGFR in sarcosine Pilot purification of tj-EGFR in sarcosine Hitrap Chelating SepharoseHitrap Chelating Sepharose

m S FT W1 W2 Em S FT W1 W2 E

m – marker (Precision Plus)m – marker (Precision Plus)S – sample before application S – sample before application (solubilized protein)(solubilized protein)FT – flow-throughFT – flow-throughW1 – wash 1W1 – wash 1W2 – wash 2W2 – wash 2E – elution E – elution

2020

1515

2525

1010

Page 23: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

2323

buffer A = 50 mM NaP pH 7.0, buffer A = 50 mM NaP pH 7.0, 0.2% (w/v) N-lauryl sarcosine0.2% (w/v) N-lauryl sarcosinebuffer B = buffer A + 1 M NaClbuffer B = buffer A + 1 M NaCl

Pilot purification of tj-EGFR in sarcosine Pilot purification of tj-EGFR in sarcosine on Mini S 4.6/50 PEon Mini S 4.6/50 PE

Pilot purification of tj-EGFR in sarcosine Pilot purification of tj-EGFR in sarcosine on Mini S 4.6/50 PEon Mini S 4.6/50 PE

b m 3 5 13 15 17 19 21 b m 3 5 13 15 17 19 21 2323

25 27 29 31 33 35 37 39 41 m25 27 29 31 33 35 37 39 41 m

m – marker (BenchMark)m – marker (BenchMark)b – sample before applicationb – sample before application

1515

1010

20201515

1010

2020

Page 24: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

2424

buffer A = 300 mM NaCl, 50 mM NaP buffer A = 300 mM NaCl, 50 mM NaP pH 8.0, 0.15% (w/v) N-lauryl sarcosinepH 8.0, 0.15% (w/v) N-lauryl sarcosine

Pilot purification of tj-EGFR in sarcosine on Pilot purification of tj-EGFR in sarcosine on Peptide Superdex 10/300 GLPeptide Superdex 10/300 GL

Pilot purification of tj-EGFR in sarcosine on Pilot purification of tj-EGFR in sarcosine on Peptide Superdex 10/300 GLPeptide Superdex 10/300 GL

m 17 18 19 20 21 22 23 24 25m 17 18 19 20 21 22 23 24 25

m – marker (BenchMark)m – marker (BenchMark)

Page 25: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

2525

buffer A = 8 M urea, 50 mM NaP pH 8.0buffer A = 8 M urea, 50 mM NaP pH 8.0buffer B = buffer A + 500 mM imidazolebuffer B = buffer A + 500 mM imidazole

Pilot purification of tj-EGFR in urea on Pilot purification of tj-EGFR in urea on HiTrap Chelating 1 mlHiTrap Chelating 1 ml

Pilot purification of tj-EGFR in urea on Pilot purification of tj-EGFR in urea on HiTrap Chelating 1 mlHiTrap Chelating 1 ml

c m b 2 10 12 14 16 18 20c m b 2 10 12 14 16 18 20

c – crude cell extract solubilized in 8 M ureac – crude cell extract solubilized in 8 M uream – marker (BenchMark)m – marker (BenchMark)b – sample before application (supernatant), in 8 M ureab – sample before application (supernatant), in 8 M urea

Page 26: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

2626

buffer A = 8 M urea, 25 mM NaOAc pH 4.5buffer A = 8 M urea, 25 mM NaOAc pH 4.5

Pilot purification of tj-EGFR in urea on Pilot purification of tj-EGFR in urea on Peptide Superdex 10/300 GLPeptide Superdex 10/300 GL

Pilot purification of tj-EGFR in urea on Pilot purification of tj-EGFR in urea on Peptide Superdex 10/300 GLPeptide Superdex 10/300 GL

m 5 13 14 15 16 17 18 19 20m 5 13 14 15 16 17 18 19 20

m – marker (BenchMark)m – marker (BenchMark)

1515

1010

2020

Page 27: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

2727

buffer A = 300 mM NaCl, 50 mM NaP pH 8.0buffer A = 300 mM NaCl, 50 mM NaP pH 8.0buffer B = buffer A + 500 mM imidazolebuffer B = buffer A + 500 mM imidazole

Pilot purification of tj-EGFR HiTrap Chelating 1mlPilot purification of tj-EGFR HiTrap Chelating 1mlPilot purification of tj-EGFR HiTrap Chelating 1mlPilot purification of tj-EGFR HiTrap Chelating 1ml

m b 1 3 10 11 12 13 14 15m b 1 3 10 11 12 13 14 15 16 18 20 22 24 25 26 27 29 m16 18 20 22 24 25 26 27 29 m

m – marker (BenchMark)m – marker (BenchMark)b – sample before applicationb – sample before application

m b 1 11 12 13 14 15 16 18m b 1 11 12 13 14 15 16 18

1515

1010

20201515

1010

2020

Page 28: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

2828

buffer A = 50 mM NaP pH 8.0buffer A = 50 mM NaP pH 8.0buffer B = buffer A + 1 M NaClbuffer B = buffer A + 1 M NaCl

Pilot purification of tj-EGFR on HiTrap SP FF 1 mlPilot purification of tj-EGFR on HiTrap SP FF 1 mlPilot purification of tj-EGFR on HiTrap SP FF 1 mlPilot purification of tj-EGFR on HiTrap SP FF 1 ml

b m 2 4 15 16 17 19 20 21b m 2 4 15 16 17 19 20 21 23 25 27 29 31 32 33 34 35 m23 25 27 29 31 32 33 34 35 m

m – marker (BenchMark)m – marker (BenchMark)b – sample before applicationb – sample before application

1515

1010

20201515

1010

2020

Page 29: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

2929

What is yet to be done with tj-EGFRWhat is yet to be done with tj-EGFRWhat is yet to be done with tj-EGFRWhat is yet to be done with tj-EGFR

Compare the CD results with the new constructCompare the CD results with the new construct

7His-transmembrane+juxtamembrane-StrepII7His-transmembrane+juxtamembrane-StrepII

Investigate dimerization (depends on Investigate dimerization (depends on lipids/detergent?!)lipids/detergent?!)

Characterize in detail by CD spectroscopy under Characterize in detail by CD spectroscopy under various conditionsvarious conditions

Crystallize, do Crystallize, do 1515N-NMRN-NMR

Page 30: 1 Epidermal Growth Factor Receptor (EGFR) the transmembrane + juxtamembrane domains L1CR1L2CR2 JM KinaseCT 644 1513124816216879551186 Extracellular portionIntracellular.

3030

THANKS FOR YOUR ATTENTIONTHANKS FOR YOUR ATTENTIONTHANKS FOR YOUR ATTENTIONTHANKS FOR YOUR ATTENTION